You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 290 No. 2, July 9, 2003 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Anemias
 •Immunology, Other
 •Alert me on articles by topic

Aplastic Anemia and Immunosuppression

Since this article does not have an abstract, we have provided the first 129 words of the full text and any section headings.

To the Editor: In their article about antithymocyte globulin and cyclosporine for severe aplastic anemia, Dr Rosenfeld and colleagues1 did not discuss Good and colleagues'2 1956 description of an associated syndrome of gammaglobulinemia, presumably due to immune suppression, in patients with benign thymic tumors. In our clinical experience, we have found that this syndrome can be associated with severe aplastic anemia and vitiligo. Although these findings do not necessarily respond to intravenous {gamma} globulin or antithymocyte globulin, we have found that cyclosporine may lead to a dramatic response. Rosenfeld et al, however, did not indicate whether their patients had signs of immunosuppression, such as hypogammaglobulinemia, hypothyroidism, pernicious anemia, or vitiligo.

Stephen M. Nagy, Jr, MD; John J. Fisher, MD
Department of Internal Medicine
School of Medicine
University of California, Davis

1. Rosenfeld S, Follmann D, Nunez O, Young NS. Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome. JAMA. 2003;289:1130-1135. FREE FULL TEXT
2. Good RA. Thymic tumor and acquired agammaglobulinemia: a clinical and experimental study of the immune response. Surgery. 1956;40:1010-1017. PUBMED

Letters Section Editor: Stephen J. Lurie, MD, PhD, Senior Editor.

JAMA. 2003;290:193.


RELATED ARTICLES

Aplastic Anemia and Immunosuppression—Reply
Neal S. Young and Stephen Rosenfeld
JAMA. 2003;290(2):193.
EXTRACT | FULL TEXT  

Antithymocyte Globulin and Cyclosporine for Severe Aplastic Anemia: Association Between Hematologic Response and Long-term Outcome
Stephen Rosenfeld, Dean Follmann, Olga Nunez, and Neal S. Young
JAMA. 2003;289(9):1130-1135.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.